SGStephen Goodall

Stephen Goodall

*This is an algorithmically generated author record based on publicly available information.

Stephen Goodall has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Dion Auriac

    Vapotronics Limited, Clunies Ross Centre, Eight Mile Plains, Queensland Australia

    1 shared publication
  • Kim Chan

    Faculty of Pharmacy, University of Sydney, Sydney, Australia

    1 shared publication
  • Michael J. Waters

    Department of Physiology and Pharmacology, University of Queensland, St. Lucia, Queensland Australia

    1 shared publication
  • Nora Chew

    Faculty of Pharmacy, University of Sydney, Sydney, Australia

    1 shared publication

Latest Publications

  • Aerosolization of Protein Solutions Using Thermal Inkjet Technology

    by Stephen Goodall, Nora Chew, Kim Chan, Dion Auriac, Michael J. Waters

    Vapotronics Inc. is developing the thermal inkjet (TIJ) technology used extensively in the printer industry to create a digital aerosol inhaler for the inhalation of therapeutics for local and systemic delivery. The operation of thermal inkjet printers requires generation of high temperatures and vaporization of the liquid formulation to effect droplet ejection. A study was conducted to develop formulations that would permit the generation of aerosols of therapeutic proteins without damage to the inkjet system or degradation of the proteins. Two proteins, human growth hormone and insulin, were formulated and aerosolized. The aerosol was collected and subjected to assays to compare the physicochemical and biological activities of these proteins before and after aerosolization. In each case, there was no significant changes to the proteins as a result of the aerosolization, providing evidence that TIJ can be used for aerosolizing solutions of protein therapeutics.